Keñya Edmondson

Keñya Edmondson has an extensive work experience in the pharmaceutical industry. In 2009, they joined Pfizer Pharmaceuticals as a Senior Director, overseeing Parenterals Operations. After almost a decade in this role, they transitioned to Novartis Gene Therapies in 2018, serving as the Vice President of External Manufacturing & Strategic Sourcing. In 2021, Keñya joined Jaguar Gene Therapy as the Vice President of Program Management & Strategy. Currently, they are working at Pfizer as the Vice President of Sterile Injectables Operations, a position they assumed in 2022.

Keñya Edmondson obtained a Bachelor's degree in Pre-Med Biology from Hampton University, starting in 1988 and completing in 1991. Subsequently, they pursued a Master's degree in Industrial Pharmacy at Long Island University, which they accomplished between the years 1994 and 1996.